methadone has been researched along with Menopause in 5 studies
Methadone: A synthetic opioid that is used as the hydrochloride. It is an opioid analgesic that is primarily a mu-opioid agonist. It has actions and uses similar to those of MORPHINE. (From Martindale, The Extra Pharmacopoeia, 30th ed, p1082-3)
methadone : A racemate comprising equimolar amounts of dextromethadone and levomethadone. It is a opioid analgesic which is used as a painkiller and as a substitute for heroin in the treatment of heroin addiction.
6-(dimethylamino)-4,4-diphenylheptan-3-one : A ketone that is heptan-3-one substituted by a dimethylamino group at position 6 and two phenyl groups at position 4.
Menopause: The last menstrual period. Permanent cessation of menses (MENSTRUATION) is usually defined after 6 to 12 months of AMENORRHEA in a woman over 45 years of age. In the United States, menopause generally occurs in women between 48 and 55 years of age.
| Excerpt | Relevance | Reference |
|---|---|---|
| "This pilot study explores somatic, psychological, and urogenital menopause symptoms associated with HIV drug and sexual risk among midlife women with substance abuse histories in methadone maintenance treatment." | 7.79 | Relationship between menopause symptoms and HIV risk among midlife women in methadone treatment: a pilot study. ( Daneshyar, S; Kull, RM; Pennington, LE; Tuchman, E, 2013) |
| "This article describes menopause symptom attributions among 135 midlife methadone-maintained women between the ages of 40 and 55 years." | 7.76 | Menopause symptom attribution among midlife women in methadone treatment. ( Tuchman, E, 2010) |
| "Menopause is a natural process that occurs in women's lives as part of normal aging." | 5.34 | Exploring the prevalence of menopause symptoms in midlife women in methadone maintenance treatment. ( Tuchman, E, 2007) |
| "This pilot study explores somatic, psychological, and urogenital menopause symptoms associated with HIV drug and sexual risk among midlife women with substance abuse histories in methadone maintenance treatment." | 3.79 | Relationship between menopause symptoms and HIV risk among midlife women in methadone treatment: a pilot study. ( Daneshyar, S; Kull, RM; Pennington, LE; Tuchman, E, 2013) |
| "This article describes menopause symptom attributions among 135 midlife methadone-maintained women between the ages of 40 and 55 years." | 3.76 | Menopause symptom attribution among midlife women in methadone treatment. ( Tuchman, E, 2010) |
| "Menopause is a natural process that occurs in women's lives as part of normal aging." | 1.34 | Exploring the prevalence of menopause symptoms in midlife women in methadone maintenance treatment. ( Tuchman, E, 2007) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 2 (40.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (20.00) | 29.6817 |
| 2010's | 2 (40.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Tuchman, E | 3 |
| Pennington, LE | 1 |
| Kull, RM | 1 |
| Daneshyar, S | 1 |
| HEROLD, K | 1 |
| Horwitz, CA | 1 |
| Jerome, E | 1 |
| Diamond, R | 1 |
| Ward, PC | 1 |
5 other studies available for methadone and Menopause
| Article | Year |
|---|---|
Relationship between menopause symptoms and HIV risk among midlife women in methadone treatment: a pilot study.
Topics: Adult; Female; HIV Infections; Humans; Male; Menopause; Methadone; Middle Aged; Narcotics; Opiate Su | 2013 |
Menopause symptom attribution among midlife women in methadone treatment.
Topics: Adult; Cross-Sectional Studies; Female; Health Knowledge, Attitudes, Practice; Health Surveys; HIV I | 2010 |
[Polamidon as cough remedy in treatment of menopausal deficiencies with estrogens].
Topics: Contraceptive Agents, Female; Cough; Estradiol Congeners; Estrogens; Female; Humans; Menopause; Meth | 1953 |
Exploring the prevalence of menopause symptoms in midlife women in methadone maintenance treatment.
Topics: Adult; Chi-Square Distribution; Cross-Sectional Studies; Depression; Female; Health Surveys; HIV Inf | 2007 |
Evaluation of a latex tube agglutination-inhibition pregnancy test. An analysis of 1,776 specimens.
Topics: Adult; Agglutination Tests; Antibodies; Chorionic Gonadotropin; Chromatography, Thin Layer; Evaluati | 1973 |